-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
Highlights from the RegMed XB 1st Annual Conference
Leading experts gathered to explore the future of healthcare. The RegMed XB 1st Annual Conference on regenerative medicine brought together more than 200 attendees from around the world.
read more
Medical Scientific Director RegMed XB speaks at ISCT Annual Meeting
The ISCT Annual Meeting is the largest global forum about cell and gene therapy that took places in Paris from May 31 – June 3 2023.
read more
Symposium on Regenerative Medicine in Osaka Japan and online
On Friday the 19th of May 2023, from 09.30 – 11.30, The Consulate General of the Kingdom of the Netherlands in Osaka organizes the second day of the symposium on Regenerative Medicine in the Netherlands and Japan. With over 300 attendees, the first day of this hybrid event was a resounding success and a true showcase of the vibrant scientific community in both countries.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
